FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-7724com.
(The FASEB Journal. 2007;21:2442-2454.)
© 2007 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.06-7724comv1
fj.06-7724comv2
21/10/2442    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baltz, K. M.
Right arrow Articles by Salih, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baltz, K. M.
Right arrow Articles by Salih, H. R.

Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions

Katrin M. Baltz*,1, Matthias Krusch*,1, Anita Bringmann*, Peter Brossart*, Frank Mayer*, Mercedes Kloss*, Tina Baessler*, Ingrid Kumbier*, Andrea Peterfi*, Susan Kupka{dagger}, Stefan Kroeber{ddagger}, Dagmar Menzel§, Markus P. Radsak||, Hans-Georg Rammensee and Helmut R. Salih*,2

* Department of Internal Medicine,

{dagger} Department of Surgery,

{ddagger} Department of Pathology,

§ Center of Clinical Transfusion Medicine, Eberhard Karls-University, Tübingen, Germany;

Department of Internal Medicine, Johannes Gutenberg-University, Mainz, Germany; and

|| Department of Immunology, Eberhard Karls-University, Tübingen, Germany

2Correspondence: Department of Internal Medicine, Eberhard-Karls University, Otfried-Mueller-Str. 10, D-72076 Tuebingen, Germany. E-mail: helmut.salih{at}med.uni-tuebingen.de

Glucocorticoid-induced TNF-related protein (GITR) has been shown to stimulate T cell-mediated antitumor immunity in mice. However, the functional relevance of GITR and its ligand (GITRL) for non-T cells has yet to be fully explored. In addition, recent evidence suggests that GITR plays different roles in mice and humans. We studied the role of GITR-GITRL interaction in human tumor immunology and report for the first time that primary gastrointestinal cancers and tumor cell lines of different histological origin express substantial levels of GITRL. Signaling through GITRL down-regulated the expression of the immunostimulatory molecules CD40 and CD54 and the adhesion molecule EpCAM, and induced production of the immunosuppressive cytokine TGF-ß by tumor cells. On NK cells, GITR is constitutively expressed and up-regulated following activation. Blocking GITR-GITRL interaction in cocultures of tumor cells and NK cells substantially increased cytotoxicity and IFN-{gamma} production of NK cells demonstrating that constitutive expression of GITRL by tumor cells diminishes NK cell antitumor immunity. GITRL-Ig fusion protein or cell surface-expressed GITRL did not induce apoptosis in NK cells, but diminished nuclear localized c-Rel and RelB, indicating that GITR might negatively modulate NK cell NF-{kappa}B activity. Taken together, our data indicate that tumor-expressed GITRL mediates immunosubversion in humans.—Baltz, K. M., Krusch, M., Bringmann, A., Brossart, P., Mayer, F., Kloss, M., Baessler, T., Kumbier, I., Peterfi, A., Kupka, S., Kroeber, S., Menzel, D., Radsak, M. P., Rammensee, H-G., Salih, H. R. Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions.


Key Words: tumor immunity • TNF family • TNFRSF18 • immune escape




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. Nocentini, S. Cuzzocrea, T. Genovese, R. Bianchini, E. Mazzon, S. Ronchetti, E. Esposito, D. P. Rosanna, P. Bramanti, and C. Riccardi
Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related (GITR)-Fc Fusion Protein Inhibits GITR Triggering and Protects from the Inflammatory Response after Spinal Cord Injury
Mol. Pharmacol., June 1, 2008; 73(6): 1610 - 1621.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. C. Lutsiak, Y. Tagaya, A. J. Adams, J. Schlom, and H. Sabzevari
Tumor-Induced Impairment of TCR Signaling Results in Compromised Functionality of Tumor-Infiltrating Regulatory T Cells
J. Immunol., May 1, 2008; 180(9): 5871 - 5881.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Liu, Z. Li, S. P. Mahesh, S. Pantanelli, F. S. Hwang, W. O. Siu, and R. B. Nussenblatt
Glucocorticoid-induced Tumor Necrosis Factor Receptor Negatively Regulates Activation of Human Primary Natural Killer (NK) Cells by Blocking Proliferative Signals and Increasing NK Cell Apoptosis
J. Biol. Chem., March 28, 2008; 283(13): 8202 - 8210.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Nishikawa, T. Tsuji, E. Jager, G. Briones, G. Ritter, L. J. Old, J. E. Galan, H. Shiku, and S. Gnjatic
Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector
Blood, February 1, 2008; 111(3): 1404 - 1412.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Chattopadhyay, U. A. Ramagopal, A. Mukhopadhaya, V. N. Malashkevich, T. P. DiLorenzo, M. Brenowitz, S. G. Nathenson, and S. C. Almo
Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function
PNAS, December 4, 2007; 104(49): 19452 - 19457.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The Federation of American Societies for Experimental Biology.